Skip to main navigation
  • Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer
VectivBio

VectivBio

Transforming Lives

Site - Header Menu

  • About Us
    • Management Team
    • Board Members
    • Investors
    • Partners
  • Our Focus
    • Our Science
    • Our Pipeline
    • Our Clinical Trials
  • Investors & Media
    • Overview
    • News & Media
    • Events & Presentations
    • Annual General Meeting
    • Extraordinary General Meeting
    • Financial Information
    • Stock Information
    • Corporate Governance
    • Shareholder Resources
  • Contact Us
    • Careers

SEC Filings

Filing date Form Description Filing Group View
Feb 14, 2023 SC 13G/A

An amendment to the SC 13G filing

Other
0000947871-23-000190.pdf
0000947871-23-000190.rtf
0000947871-23-000190.xls
View HTML
Feb 13, 2023 SC 13G/A

An amendment to the SC 13G filing

Other
0001085146-23-001077.pdf
0001085146-23-001077.rtf
0001085146-23-001077.xls
View HTML
Feb 2, 2023 SC 13G/A

An amendment to the SC 13G filing

Other
0001193125-23-022515.pdf
0001193125-23-022515.rtf
0001193125-23-022515.xls
View HTML
Feb 1, 2023 UPLOAD

UPLOAD

Other
0000000000-23-001022.pdf
0000000000-23-001022.rtf
View HTML
Jan 27, 2023 F-3

Registration statement for certain foreign private issuers offered for certain transactions

Registration Statements
0001193125-23-017769.pdf
0001193125-23-017769.rtf
0001193125-23-017769.xls
View HTML
Jan 27, 2023 S-8

Securities offered to employees pursuant to employee benefit plans

Registration Statements
0001193125-23-017775.pdf
0001193125-23-017775.rtf
0001193125-23-017775.xls
View HTML
Jan 10, 2023 6-K

Report of foreign issuer rules 13a-16 and 15d-16 of the Securities Exchange Act

Current Reports
0001193125-23-005594.pdf
0001193125-23-005594.rtf
0001193125-23-005594.xls
View HTML
Dec 30, 2022 6-K

Report of foreign issuer rules 13a-16 and 15d-16 of the Securities Exchange Act

Current Reports
0001193125-22-315417.pdf
0001193125-22-315417.rtf
0001193125-22-315417.xls
View HTML
Dec 13, 2022 SC 13D/A

An amendment to a SC 13D filing

Other
0001193125-22-303760.pdf
0001193125-22-303760.rtf
0001193125-22-303760.xls
View HTML
Dec 9, 2022 6-K

Report of foreign issuer rules 13a-16 and 15d-16 of the Securities Exchange Act

Current Reports
0001193125-22-301893.pdf
0001193125-22-301893.rtf
0001193125-22-301893.xls
View HTML

Pagination

  • First page « First
  • Previous page ‹ Previous
  • Page 1
  • Page 2
  • Current page 3
  • Page 4
  • Page 5
  • Page 6
  • Page 7
  • Page 8
  • Page 9
  • Next page Next ›
  • Last page Last »

Data provided by Kaleidoscope.

Primary Sidebar

INVESTORS & MEDIA

  • Overview
  • News & Media
    • Press Releases
  • Events & Presentations
  • Annual General Meeting
  • Extraordinary General Meeting
  • Financial Information
    • SEC Filings
    • Annual Reports
    • Quarterly Reports
  • Stock Information
    • Historical Stock Price Lookup
    • Investment Calculator
    • Analyst Coverage
  • Corporate Governance
    • Documents & Charters
    • Management Team
    • Board Members
    • Committee Composition
  • Shareholder Resources
    • FAQs
    • Email Alerts
    • Contact IR
    • RSS Feeds

Site - Shareholder Tools

Email Alerts Print Search

IR CONTACT

ir@vectivbio.com

 

Footer

Site - Footer Menu Left

VectivBio

Site - Footer Menu Center

Terms of Use Privacy Policy

Copyright © VectivBio AG, 2023. All Rights Reserved.

Site - Footer Menu Right

  • About Us
  • Our Focus
  • Investors & Media
  • Contact Us

Site - Header Menu

  • About Us
    • Management Team
    • Board Members
    • Investors
    • Partners
  • Our Focus
    • Our Science
    • Our Pipeline
    • Our Clinical Trials
  • Investors & Media
    • Overview
    • News & Media
    • Events & Presentations
    • Annual General Meeting
    • Extraordinary General Meeting
    • Financial Information
    • Stock Information
    • Corporate Governance
    • Shareholder Resources
  • Contact Us
    • Careers